Insider Transactions Reported by 29 Insiders of Jade Biosciences, Inc.

Symbol
JBIO on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

Jade Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sofinnova Venture Partners X, L.P. 10%+ Owner $73,294,377 02 Jul 2021
DAVID S. GRAYZEL Director $50,853,006 05 Jun 2024
Fairmount Funds Management LLC Director, 10%+ Owner $48,084,557 06 Oct 2025
Atlas Venture Fund XII, L.P. 10%+ Owner $45,394,226 15 Jul 2022
Cormorant Asset Management, LP Former 10% Owner $39,598,475 02 Jul 2021
TIMOTHY P. NOYES CHIEF EXECUTIVE OFFICER, Director $5,621,147 16 May 2024
RA CAPITAL MANAGEMENT, L.P. 10%+ Owner $3,437,148 28 Apr 2025
Hunter Gillies Chief Medical Officer $1,504,308 13 Jun 2024
Marinus Verwijs Chief Technical Officer $1,126,256 14 Jun 2024
Timothy Pigot Chief Commercial Officer $923,420 22 Jan 2024
Andrew James King Exhibit 24 - Power of Attorney Chief Scientific Officer & Head of Research and Development $917,335 28 Apr 2025
George A. Eldridge Officer Title: Chief Financial Officer and Treasurer $596,551 14 Jun 2024
RALPH NIVEN Chief Scientific Officer $591,035 05 Feb 2024
Lawrence Otto Klein Director $229,331 29 Apr 2025
Habib J. Dable Director $204,625 05 Jun 2024
Joshua Resnick Director $204,625 05 Jun 2024
Donald J. Santel Director $204,625 05 Jun 2024
Mark T. Iwicki Director $204,625 05 Jun 2024
Maha Katabi Director, 10%+ Owner $204,625 05 Jun 2024
Allison Dorval Director $204,625 05 Jun 2024
Tom Frohlich Chief Executive Officer, Director $44,400 +$44,400 16 May 2025
Benjamin T. Dake Officer Title: President, Chief Operating Officer and Secretary $24,798 31 Jul 2024
Hetal Kocinsky Chief Medical Officer 28 Apr 2025
Elizabeth Balta Exhibit 24 - Power of Attorney General Counsel and Corporate Secretary 28 Apr 2025
ERIC DOBMEIER Director 29 Apr 2025
CHRISTOPHER W. CAIN Director 29 Apr 2025
Erin Lavelle Director 29 Apr 2025
Jonathan Quick Exhibit 24 - Power of Attorney Senior Vice President, Finance and Treasurer 28 Apr 2025
Bradford D. Dahms Chief Financial Officer 14 Jul 2025

Recent Insider Transactions by Companies or Individuals for Jade Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.